Antidepressant therapy in patients with ischemic heart disease

American Heart Journal

Volumn 150, Issue 5, 2005, Pages 871-881

  Jiang, Wei ^a   Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ENCAINIDE; FLECAINIDE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIRTAZAPINE; MORACIZINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; WARFARIN;

ACUTE HEART INFARCTION; ANTIARRHYTHMIC ACTIVITY; ANTICHOLINERGIC EFFECT; BLEEDING; BLOOD TOXICITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG SAFETY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MORTALITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; TACHYCARDIA; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARDIOVASCULAR DISEASES; DEPRESSION; DRUG INTERACTIONS; HUMANS; MYOCARDIAL ISCHEMIA; RISK FACTORS; SEROTONIN ANTAGONISTS;

EID: 27744503037     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.041     Document Type: Review

References (99)

1. R.M. Carney, M.W. Rich, and A. Tevelde Major depressive disorder in coronary artery disease Am J Cardiol 60 1987 1273 1275
2. B. Rudisch, and C.B. Nemeroff Epidemiology of comorbid coronary artery disease and depression Biol Psychiatry 54 2003 227 240
3. S.J. Schleifer, M.M. Macari-Hinson, and D.A. Coyle The nature and course of depression following myocardial infarction Arch Intern Med 149 1989 1785 1789
4. N. Frasure-Smith, F. Lespérance, and M. Talajic Depression following myocardial infarction. Impact on 6-month survival JAMA 270 1993 1819 1825
5. W. Jiang, R.R. Krishnan, and C.M. O'Connor Depression and heart disease-evidence of a link, and its therapeutic implications CNS Drugs 16 2002 111 127
6. R.M. Carney, M.W. Rich, and K.E. Freedland Major depressive disorder predicts cardiac events in patients with coronary artery disease Psychosom Med 50 1988 627 633
7. K.H. Ladwig, M. Kieser, and J. Konig Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study Eur Heart J 12 1991 959 964
8. K.H. Ladwig, G. Roll, and G. Breithardt Post-infarction depression and incomplete recovery 6 months after myocardial infarction Lancet 343 1994 20 23
9. N. Frasure-Smith, F. Lespérance, and M. Talajic Depression and 18-month prognosis after myocardial infarction Circulation 91 1995 999 1005
10. J.C. Barefoot, M.J. Helms, and D.B. Mark Depression and long-term mortality risk in patients with coronary artery disease Am J Cardiol 78 1996 613 617
11. T.A. Murberg, E. Bru, and S. Svebak Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study Int J Psychiatry Med 29 1999 311 326
12. M. Horsten, M.A. Mittleman, and S.P. Wamala Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study Eur Heart J 21 2000 1072 1080
13. F. Lespérance, N. Frasure-Smith, and M. Juneau Depression and 1-year prognosis in unstable angina Arch Intern Med 160 2000 1354 1360
14. R.A. Baker, M.J. Andrew, and G. Schrader Preoperative depression and mortality in coronary artery bypass surgery: preliminary findings ANZ J Surg 71 2001 139 142
15. K.E. Freedland, and R.M. Carney Psychosocial considerations in elderly patients with heart failure Clin Geriatr Med 16 2000 649 661
16. P.E. McGann Comorbidity in heart failure in the elderly Clin Geriatr Med 16 2000 631 648
17. D.E. Ford, L.A. Mead, and P.P. Chang Depression is a risk factor for coronary artery disease in men: the precursors study Arch Intern Med 158 1998 1422 1426
18. A.K. Ferketich, J.A. Schwartzbaum, and D.J. Frid Depression as an antecedent to heart disease among women and men in the NHANES I study Arch Intern Med 160 2000 1261 1268
19. B.W. Penninx, A.T. Beekman, and A. Honig Depression and cardiac mortality: results from a community-based longitudinal study Arch Gen Psychiatry 58 2001 221 227
20. S.P. Roose Treatment of depression in patients with heart disease Biol Psychiatry 54 2003 262 268
21. S. Wassertheil-Smoller, W.B. Applegate, and K. Berge Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly) Arch Intern Med 156 1996 553 561
22. B.W. Penninx, J.M. Guralnik, and C.F. Mendes de Leon Cardiovascular events and mortality in newly and chronically depressed persons >70 years of age Am J Cardiol 81 1998 988 994
23. R.M. Carney, and K.E. Freedland Depression, mortality, and medical morbidity in patients with coronary heart disease Biol Psychiatry 54 2003 241 247
24. P.K. Stein, R.M. Carney, and K.E. Freedland Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease J Psychosom Res 48 2000 493 500
25. R.M. Carney, J.A. Blumenthal, and P.K. Stein Depression, heart rate variability, and acute myocardial infarction Circulation 104 2001 2024 2028
26. D.S. Sheps, and D. Sheffield Depression, anxiety, and the cardiovascular system: the cardiologist's perspective J Clin Psychiatry 62 Suppl 8 2001 12 16
27. R. Carney, K. Freedland, and G. Miller Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanisms J Psychosom Res 53 2002 897 902
28. V.K. Yeragani, K.A. Rao, and M.R. Smitha Diminished chaos of heart rate time series in patients with major depression Biol Psychiatry 51 2002 733 744
29. M.W. Agelink, T. Majewski, and C. Wurthmann Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone J Affect Disord 62 2001 187 198
30. R.C. Ziegelstein, J.A. Fauerbach, and S.S. Stevens Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction Arch Intern Med 160 2000 1818 1823
31. W. Jiang, M.A. Babyak, and A. Rozanski Depression and increased myocardial ischemic activity in patients with ischemic heart disease Am Heart J 146 2003 55 61
32. C.L. Raison, and A.H. Miller The neuroimmunology of stress and depression Semin Clin Neuropsychiatry 6 2001 277 294
33. A. Schuld, D.A. Schmid, and M. Haack Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone J Psychiatr Res 37 2003 463 470
34. H. Anisman, and Z. Merali Cytokines, stress and depressive illness: brain-immune interactions Ann Med 35 2003 2 11
35. M. Corcos, O. Guilbaud, and L. Hjalmarsson Cytokines and depression: an analogic approach Biomed Pharmacother 56 2002 105 110
36. G. Kenis, and M. Maes Effects of antidepressants on the production of cytokines Int J Neuropsychopharmacol 5 2002 401 412
37. A. Steptoe, S.R. Kunz-Ebrecht, and N. Owen Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women Psychol Med 33 2003 667 674
38. S. Prestele, J. Aldenhoff, and J. Reiff The HPA-axis as a possible link between depression, diabetes mellitus and cognitive dysfunction Fortschr Neurol Psychiatr 71 2003 24 36
39. P.J. Lustman, L.S. Griffith, and J.A. Gavard Depression in adults with diabetes Diabetes Care 15 1992 1631 1639
40. S.P. Roose, F. Laghrissi-Thode, and J.S. Kennedy Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease JAMA 279 1998 287 291
41. J.C. Nelson, J.S. Kennedy, and B.G. Pollock Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease Am J Psychiatry 156 1999 1024 1028
42. A.T. Beck, C.H. Ward, and M. Mendelson An inventory for measuring depression Arch Gen Psychiatry 4 1961 561 571
43. J.M. Zich, C.C. Attkisson, and T.K. Greenfield Screening for depression in primary care clinics: the CES-D and the BDI Int J Psychiatry Med 20 1990 259 277
44. N. Frasure-Smith, F. Lesperance, and M. Talajic Depression following myocardial infarction: impact on 6-month survival JAMA 270 1993 1819 1825
45. K. Kroenke, R.L. Spitzer, and J.B. Williams The PHQ-9: validity of a brief depression severity measure J Gen Intern Med 16 2001 606 613
46. L.S. Radloff, and L. Teri Use of the CES-D scale with older adults Clin Gerontol 5 1986 119 136
47. C. Herrmann International experiences with the hospital anxiety and depression scale: a review of validation data and clinical results J Psychosom Res 42 1997 17 41
48. K. Kroenke, R.L. Spitzer, and J.B. Williams The patient health questionnaire-2: validity of a two-item depression screener Med Care 41 2003 1284 1292
49. R.P. Millman, B.S. Fogel, and M.E. McNamara Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure J Clin Psychiatry 50 1989 348 351
50. A.S. Baran, and A.C. Richert Obstructive sleep apnea and depression [Review] CNS Spectr 8 2003 128 134
51. F. Roux, C. D'Ambrosio, and V. Mohsenin Sleep-related breathing disorders and cardiovascular disease [Review] Am J Med 108 2000 396 402
52. P. Dahlof, H. Ejnell, and T. Hallstrom Surgical treatment of the sleep apnea syndrome reduces associated major depression Int J Behav Med 7 2000 73 88
53. K. O'Sullivan Depression and its treatment in alcoholics: a review [Review] Can J Psychiatry 29 1984 379 384
54. A.I. Qureshi, M.F. Suri, and L.R. Guterman Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey Circulation 103 2001 502 506
55. B.J. Rounsaville, S.F. Anton, and K. Carroll Psychiatric diagnoses of treatment-seeking cocaine abusers Arch Gen Psychiatry 48 1991 43 51
56. H. Michelsen, and C. Bildt Psychosocial conditions on and off the job and psychological ill health: depressive symptoms, impaired psychological wellbeing, heavy consumption of alcohol Occup Environ Med 60 2003 489 496
57. E.R. Weitzman Poor mental health, depression, and associations with alcohol consumption, harm, and abuse in a national sample of young adults in college J Nerv Ment Dis 192 2004 269 277
58. S.P. Roose, and E. Spatz Treating depression in patients with ischaemic heart disease. Which agents are best to use and to avoid? Drug Saf 20 1999 459 465
59. Cardiac Arrhythmia Suppression Trial Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 412
60. Cardiac Arrhythmia Suppression Trial II Investigators Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction N Engl J Med 327 1992 227 233
61. H.M. Greenberg, E.M. Dwyer Jr, and J.S. Hochman Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I Br Heart J 74 1995 631 635
62. J. Hippisley-Cox, M. Pringle, and V. Hammersley Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care BMJ 323 2001 666 669
63. S.A. Montgomery, A.T.F. Beekman, and J. Sadavoy Consensus statement on depression in the elderly Prim Care Companion J Clin Psychiat 2 Suppl 5 2000 46 52
64. W.E. Heydorn The use of citalopram in patients with cardiovascular disease Am J Geriatr Psychiatry 8 2000 23 24 [Abstracts from the American Association for Geriatric Psychiatry 13th Annual Meeting, March 12-15, 2000, Miami Beach, Fla].
65. S.L. Rasmussen, K.F. Overo, and P. Tanghoj Cardiac safety of citalopram: prospective trials and retrospective analyses J Clin Psychopharmacol 19 1999 407 415
66. S.P. Roose, A.H. Glassman, and E. Attia Cardiovascular effects of fluoxetine in depressed patients with heart disease Am J Psychiatry 155 1998 660 665
67. J.J. Strik, A. Honig, and R. Lousberg Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial Psychosom Med 62 2000 783 789
68. P.A. Shapiro, F. Lesperance, and N. Frasure-Smith An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHART trial). Sertraline Anti-Depressant Heart Attack Trial Am Heart J 137 1999 1100 1106
69. A.H. Glassman, C.M. O'Connor, and R.M. Califf Sertraline treatment of major depression in patients with acute MI or unstable angina JAMA 288 2002 701 709
70. L.F. Berkman, J. Blumenthal, and M. Burg Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial JAMA 289 2003 3106 3116
71. K.R.R. Krishnan, P.M. Doraiswamy, and C.M. Clary Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline Prog Neuropsychopharmacol Biol Psychiatry 25 2001 347 361
72. W.H. Sauer, J.A. Berlin, and S.E. Kimmel Selective serotonin reuptake inhibitors and myocardial infarction Circulation 104 2001 1894 1898
73. A. McFarlane, M.V. Kamath, and E.L. Fallen Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction Am Heart J 142 2001 617 623
74. V.K. Yeragani, V. Pesce, and A. Jayaraman Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures Biol Psychiatry 52 2002 418 429
75. V.K. Yeragani, S. Roose, and M. Mallavarapu Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate Neuropsychobiology 46 2002 125 135
76. T. Rechlin The effects of psychopharmacological therapy on heart rate variation Nervenarzt 66 1995 678 685
77. D. Ziegler, G. Laux, and K. Dannehl Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses Diabet Med 9 1992 166 175
78. D. Ziegler, F.A. Gries, and M. Spuler The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group J Diabetes Complications 6 1992 49 57
79. Y. Khaykin, P. Dorian, and B. Baker Autonomic correlates of antidepressant treatment using heart-rate variability analysis Can J Psychiatry 43 1998 183 186
80. I. Kawachi, G.A. Colditz, and A. Ascherio Prospective study of phobic anxiety and risk of coronary heart disease in men Circulation 89 1994 1992 1997
81. I. Kawachi, D. Sparrow, and P.S. Vokonas Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study Circulation 90 1994 2225 2229
82. P. Tucker, P. Adamson, and R. Miranda Paroxetine increases heart rate variability in panic disorder J Clin Psychopharmacol 17 1997 370 376
83. V.K. Yeragani, R. Pohl, and V.C. Jampala Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder Depress Anxiety 11 2000 126 130
84. B.G. Pollock, F. Laghrissi-Thode, and W.R. Wagner Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment J Clin Psychopharmacol 20 2000 137 140
85. D.L. Musselman, U.M. Marzec, and A. Manatunga Platelet reactivity in depressed patients treated with paroxetine-preliminary findings Arch Gen Psychiatry 57 2000 875 882
86. V.L. Serebruany, A.H. Glassman, and A.I. Malinin Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Platelet substudy Circulation 108 2003 939 944
87. K. Brosen Differences in interactions of SSRIs Int Clin Psychopharmacol 13 Suppl 5 1998 S45 S47
88. D.J. Greenblatt, L.L. von Moltke, and J.S. Harmatz Drug interactions with newer antidepressants: role of human cytochromes P450 J Clin Psychiatry 59 Suppl 15 1998 19 27
89. I.S. Khawaja, and R.E. Feinstein Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants Heart Dis 5 2003 153 160
90. C.B. Nemeroff, C.L. DeVane, and B.G. Pollock Newer antidepressants and the cytochrome P450 system Am J Psychiatry 153 1996 311 320
91. S.P. Roose, G.W. Dalack, and A.H. Glassman Cardiovascular effects of bupropion in depressed patients with heart disease Am J Psychiatry 148 1991 512 516
92. P.R. Saxena, and C.M. Villalon Cardiovascular effects of serotonin agonists and antagonists J Cardiovasc Pharmacol 15 Suppl 7 1990 S17 S34
93. J.P. Feighner Cardiovascular safety in depressed patients: focus on venlafaxine J Clin Psychiatry 56 1995 574 579
94. I. Reznik, Y. Rosen, and B. Rosen An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms J Psychopharmacol 13 1999 193 195
95. D.W. Oslin, T.R. Ten Have, and J.E. Streim Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents J Clin Psychiatry 64 2003 875 882
96. A.T. Harvey, R.L. Rudolph, and S.H. Preskorn Evidence of the dual mechanisms of action of venlafaxine Arch Gen Psychiatry 57 2000 503 509
97. M.M. Shores, M. Pascualy, and N.L. Lewis Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects Psychoneuroendocrinology 26 2001 433 439
98. L. Watkins, J.R.T. Davidson, and K.M. Connor Effects of paroxetine and venlafaxine-XR on heart rate variability in depression Eur Neuropsychopharmacol 13 2003 S274
99. J.C. Ballenger, J.R.T. Davidson, and Y. Lecrubier Consensus statement on depression, anxiety, and cardiovascular disease J Clin Psychiatry 62 Suppl 8 2001 24 27